CCL2 and idiopathic pulmonary fibrosis: Interestingly, in circulating MCP-1 concentrations of patients with IPF underwent steroid therapy no trend towards fall with treatment was noticed whereas a major fluctuation in pre-and post-treatment levels was readily identifiable.